| Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines A Reimers, JA Berg, ML Burns, E Brodtkorb, SI Johannessen, ... Drug design, development and therapy, 271-280, 2018 | 120 | 2018 |
| Prevalence of alcohol and other substances of abuse among injured patients in a Norwegian emergency department ST Bogstrand, PT Normann, I Rossow, M Larsen, J Mørland, Ø Ekeberg Drug and alcohol dependence 117 (2-3), 132-138, 2011 | 112 | 2011 |
| Therapeutic drug monitoring of lacosamide in Norway: focus on pharmacokinetic variability, efficacy and tolerability T Svendsen, E Brodtkorb, A Baftiu, ML Burns, SI Johannessen, ... Neurochemical research 42, 2077-2083, 2017 | 55 | 2017 |
| Experience from therapeutic drug monitoring and gender aspects of gabapentin and pregabalin in clinical practice CJ Landmark, G Beiske, A Baftiu, ML Burns, SI Johannessen Seizure 28, 88-91, 2015 | 43 | 2015 |
| Utilisation and polypharmacy aspects of antiepileptic drugs in elderly versus younger patients with epilepsy: a pharmacoepidemiological study of CNS-active drugs in Norway … A Baftiu, SA Feet, PG Larsson, ML Burns, O Henning, E Sætre, E Molden, ... Epilepsy research 139, 35-42, 2018 | 40 | 2018 |
| Inotropic therapy in newborns, a population-based national registry study ML Burns, HJ Stensvold, K Risnes, HJ Guthe, H Astrup, SM Nordhov, ... Pediatric Critical Care Medicine 17 (10), 948-956, 2016 | 37 | 2016 |
| Therapeutic drug monitoring of clobazam and its metabolite—impact of age and comedication on pharmacokinetic variability ML Burns, A Baftiu, MS Opdal, SI Johannessen, CJ Landmark Therapeutic Drug Monitoring 38 (3), 350-357, 2016 | 34 | 2016 |
| Pharmacokinetic data on brivaracetam, lacosamide and perampanel during pregnancy and lactation CJ Landmark, L Rektorli, ML Burns, E Revdal, SI Johannessen, ... Epileptic Disorders 23 (2), 426-431, 2021 | 29 | 2021 |
| The impact of pharmacokinetic interactions with eslicarbazepine acetate versus oxcarbazepine and carbamazepine in clinical practice CJ Landmark, T Svendsen, J Dinarevic, RF Kufaas, A Reimers, ... Therapeutic Drug Monitoring 38 (4), 499-505, 2016 | 27 | 2016 |
| Long-term stability of GHB in post-mortem samples and samples from living persons, stored at− 20° C, using fluoride preservatives B Fjeld, ML Burns, R Karinen, B Larssen, A Smith-Kielland, V Vindenes Forensic science international 222 (1-3), 47-51, 2012 | 23 | 2012 |
| Pharmacokinetic variability of valproate during pregnancy–implications for the use of therapeutic drug monitoring CJ Landmark, AH Farmen, ML Burns, A Baftiu, MI Lossius, ... Epilepsy Research 141, 31-37, 2018 | 21 | 2018 |
| Pharmacokinetic variability of valproate in women of childbearing age C Johannessen Landmark, ML Burns, A Baftiu, AH Farmen, MI Lossius, ... Epilepsia 58 (10), e142-e146, 2017 | 21 | 2017 |
| Therapeutic drug monitoring of gabapentin in various indications M Larsen Burns, E Kinge, M Stokke Opdal, SI Johannessen, ... Acta Neurologica Scandinavica 139 (5), 446-454, 2019 | 19 | 2019 |
| Pharmacological aspects of antiseizure medications: From basic mechanisms to clinical considerations of drug interactions and use of therapeutic drug monitoring C Johannessen Landmark, S Eyal, ML Burns, V Franco, SI Johannessen Epileptic Disorders 25 (4), 454-471, 2023 | 18 | 2023 |
| A retrospective review of changes and challenges in the use of antiseizure medicines in Dravet syndrome in Norway K Heger, C Lund, M Larsen Burns, M Bjørnvold, E Sætre, SI Johannessen, ... Epilepsia Open 5 (3), 432-441, 2020 | 17 | 2020 |
| Long-term stability of morphine, codeine, and 6-acetylmorphine in real-life whole blood samples, stored at-20^ oC G Hoiseth, B Fjeld, ML Burns, DH Strand, V Vindenes Forensic Science International 239 (1), 6-10, 2014 | 17 | 2014 |
| Changes in the use of antiseizure medications in children and adolescents in Norway, 2009–2018 K Heger, J Skipsfjord, Y Kiselev, ML Burns, KM Aaberg, SI Johannessen, ... Epilepsy research 181, 106872, 2022 | 15 | 2022 |
| Pharmacokinetic variability and clinical use of lacosamide in children and adolescents in Denmark and Norway ML Burns, M Nikanorova, A Baftiu, JB Rasmussen, SI Johannessen, ... Therapeutic drug monitoring 41 (3), 340-347, 2019 | 14 | 2019 |
| Pharmacokinetic variability during long-term therapeutic drug monitoring of valproate, clobazam, and levetiracetam in patients with Dravet syndrome CJ Landmark, K Heger, C Lund, ML Burns, M Bjørnvold, E Sætre, ... Therapeutic Drug Monitoring 42 (5), 744-753, 2020 | 10 | 2020 |
| Long-term stability of morphine, codeine, and 6-acetylmorphine in real-life whole blood samples, stored at− 20° C G Høiseth, B Fjeld, ML Burns, DH Strand, V Vindenes Forensic Science International 239, 6-10, 2014 | 10 | 2014 |
Cecilie Johannessen LandmarkProfessor of Pharmacology, Oslo Metropolitan University/National Center for Epilepsy/Dept PharmVerifisert e-postadresse på oslomet.no
